S. 1186 · 119th Congress
Lower Drug Costs for Families Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Not yet voted on. This bill is still a proposal: it hasn't reached a floor vote, and its text can change in committee or on the floor before any vote.
D
Cortez MastoSponsor13 cosponsors · 12 D, 1 I
D
Baldwin
RB
D
Blumenthal
RG
D
Gallego
JH
D
Hickenlooper
AK
D
Klobuchar
AK
I
King
JR
D
Reed
TS
D
Smith
ES
D
Slotkin
RW
D
Wyden
PW
D
Welch
BL
D
Luján
JM
D
Merkley11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.
What it does: CRS summary · Introduced in Senate · Mar 27, 2025
Lower Drug Costs for Families Act
This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance.
Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties.
The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Lower Drug Costs for Families Act
Latest action (Mar 27, 2025): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Mar 27, 2025
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.